Biology subjects

Rosa, L.

Publications and source records attributed to Rosa, L..

4 recordsLinked to original sources

bioRxiv2023

Emergent digital bio-computation through spatial diffusion and engineered bacteria

Building computationally capable biological systems has long been an aim of synthetic biology. The potential utility of biocomputing devices ranges from biosafety and environmental applications to diagnosis and personalised medicine. Here we present work for the design of bacterial computers which use spatial patterning to process information. Our computers are composed of bacterial colonies which, inspired by patterning in embryo development, receive information in the form of diffusible morphogen-like signals. A computation is encoded by the physical locations of the input sources of morphogen and the output receiver colonies. We demonstrate, mathematically and with engineered Escherichia coli, the simple digital logic capability of single bacterial colonies and show how additional colonies are required to build complex functions. Inspired by electronic design automation, an algorithm for designing optimal spatial circuits computing two-level digital functions is presented. This enhances the capability of our system to complex digital functions without increasing the biological complexity. We extend our experimental system to incorporate biosensing colonies as morphogen sources, demonstrating how a diagnostic device might be constructed. Our approach will open up new ways to perform biological computation, with applications in bioengineering, biomaterials and biosensing. Ultimately, these computational bacterial communities will help us explore information processing in natural biological systems.

synthetic biology↗

bioRxiv2020

Pleiotropic effect of Lactoferrin in the prevention and treatment of COVID-19 infection: in vivo, in silico and in vitro preliminary evidences

Lactoferrin, a multifunctional cationic glycoprotein, secreted by exocrine glands and neutrophils, possesses an antiviral activity extendable to SARS-CoV-2. We performed in vitro assays proving lactoferrin antiviral activity through direct attachment to both virus and cell surface components. This activity varied according to concentration (100/500g/ml), multiplicity of infection (0.1/0.01) and cell type (Vero E6/Caco-2 cells). Interestingly, the in silico results strongly supported the hypothesis of a direct recognition between the lactoferrin and the Spike S glycoprotein, thus hindering the viral entry into the cells. Hence, we conducted a clinical trial to investigate effect and tolerability of a liposomal lactoferrin formulation as a supplementary nutraceutical agent in mild-to-moderate and asymptomatic COVID-19 patients. A total of 92 mild-to-moderate (67/92) and asymptomatic (25/92) COVID-19 patients were recruited and divided in 3 groups according to the administered regimen. Thirty-two patients, 14 hospitalised and 18 in home-based insolation received oral and intranasal liposomal bovine lactoferrin (bLf), 32 hospitalised patients were treated with standard of care treatment (hydroxychloroquine, azitromicin and lopinavir/darunavir), and 28, in home-based isolation, did not take any medication. Furthermore, 32 COVID-19 negative, not-treated, healthy subjects were added as a control group for ancillary analysis. bLf-supplemented COVID-19 patients obtained an earlier and significant (p < 0,0001.) median rRT-PCR SARS-COV-2 RNA negative conversion than standard of care-treated and non-treated COVID-19 patients (14.25 vs 27.13 vs 32.61 days, respectively). In addition, bLf-supplemented COVID-19 patients showed significant fast clinical symptoms recovery than standard of care-treated and non-treated COVID-19 patients. Moreover, in bLf-supplemented patients, a significant decrease of either serum ferritin or IL-6 levels or host iron overload, all parameters characterizing inflammatory processes, were observed. Serum D-dimers was also found significantly decreased following bLf supplement. No adverse events were reported. These in vitro and in vivo observations led us to speculate a potential and safe supplementary role of Blf in the management of mild-to-moderate and asymptomatic COVID-19 patients.

microbiology↗

bioRxiv2020

MORPHO-MOLECULAR MECHANISMS STUDY OF PHOTODYNAMIC THERAPY AND CURCUMIN LARVICIDE ACTION ON WILD MOSQUITOES LARVAE OF GENUS Aedes

IntroductionUntil the first two weeks of October 2019, 1.489,457 probable dengue cases have been reported in Brazil, with an incidence rate of 708.8 cases per 100 thousand inhabitants. Still in 2019, in the same period, 123.407 probable cases of chikungunya were reported, with 15 deaths confirmed by clinical and epidemiological criteria. Regarding Zika, in that period, 10.441 probable cases were recorded, been the northeast region with the highest number of notifications, followed by the midwest one. It is well known that current policies to control the vectors of those arboviruses are not effective. Studies for use of light-activated photosensitizers as an alternative to conventional insecticides for sustainable control of mosquitoes vector such as Aedes (dengue, yellow fever, chikungunya, zika), Anopheles (malaria), Culex (yellow fever) can already be found showing advantages over conventional insecticides (efficacy, safety, non-mutagenicity and fast degradation). ObjectiveTo evaluate the effectiveness of Photodynamic Therapy (PDT), mediated by curcumin and blue LED (460nm) in mortality of wild mosquitoes larvae of genus Aedes and also to verify, through confocal microscopy, how the photosensitizer internalizes in larvae organism. In addition to evaluating the action of PDT on the larvae with Raman spectroscopy and histological technique. Materials and methodsOvitraps were placed in the city of Vitoria da Conquista, Bahia, and the larvae collected in stages L2 and L3 were fed for 24 hours with curcumin in concentrations of 10, 20 and 50% mixed with fish feed and then subjected to irradiation with blue LED for 2h (22mW / cm2 and 158.4 J / cm2). The larvae were placed in a container with dechlorinated water and mortality was monitored for 24 and 48 hours. Control groups in which only the larvae were exposed to blue LED for 2 hours and in which the larvae were only fed with fish feed mixed with curcumin (10, 20 and 50%) were included in the study, in addition to the group without treatment. All experiments were repeated after a 2-month interval to confirm the results, totaling 240 tests (tests 1 and 2, n = 15) between groups PDT 10%, PDT 20%, PDT 50%, curcumin 10%, curcumin 20%, curcumin 50%, blue LED and untreated group. The larvae belonging to the PDT 20% group, 20% curcumin, blue LED and control were submitted to histological slides, confocal microscopy and Raman spectroscopy. Larvae mortality rates were compared between groups using univariate descriptive analysis. ResultsAll PDT groups showed larvicidal activity, with the PDT group 20% showing the highest larval mortality in the shortest time. The images from confocal microscopy by laser scanning showed that curcumin was distributed throughout the digestive system of larvae and the analysis by Raman microspectroscopy have shown patterns of alteration and cell death, corroborated by histological sections. ConclusionIt was concluded that PDT in all concentrations was effective in larval mortality, with PDT 20% having the best activity with mortality of 100% in 24 hours.

bioengineering↗

bioRxiv2018

Two new plasmid post-segregational killing mechanisms for the implementation of synthetic gene networks in E. coli

Plasmids are the workhorse of both industrial biotechnology and synthetic biology, but ensuring they remain in bacterial cells is a challenge. Antibiotic selection, commonly used in the laboratory, cannot be used to stabilise plasmids in most real-world applications, and inserting dynamical gene networks into the genome is difficult. Plasmids have evolved several mechanisms for stability, one of which, post-segregational killing (PSK), ensures that plasmid-free cells do not grow or survive. Here we demonstrate the plasmid-stabilising capabilities of the axe/txe two component system and the microcin-V system in the probiotic bacteria Escherichia coli Nissle 1917 and show they can outperform the hok/sok system commonly used in biotechnological applications. Using plasmid stability assays, automated flow cytometry analysis, mathematical models and Bayesian statistics we quantified plasmid stability in vitro. Further, we used an in vivo mouse cancer model to demonstrate plasmid stability in a real-world therapeutic setting. These new PSK systems, plus the developed Bayesian methodology, will have wide applicability in clinical and industrial biotechnology.

synthetic biology↗